Skip to main content

Organon

2022 Oncology Biosimilar Guide to Patient Support Services

Organon Access Program

Organon Access Program
844-326-2986
Organon Helps
888-727-0015

Organon offers The Organon Access Program to support patients who are prescribed Ontruzant (Table).

The Organon Access Program

The Organon Access Program can help answer questions about benefit investigations, the Organon Co-pay Assistance Program, and eligibility determination for referrals to the Organon Patient Assistance Program.

Organon Co-pay Assistance Program

The Organon Co-pay Assistance Program offers assistance to eligible patients who need help affording Ontruzant. Once enrolled, eligible, privately insured patients pay the first $5 of their copay per infusion with a maximum benefit of $25,000 per calendar year. Patients may be eligible for assistance if they:

  • Are residents of the United States or Puerto Rico
  • Have been prescribed Ontruzant for an FDA-approved indication
  • Have private health insurance that provides coverage for Ontruzant under a medical benefit program
  • Meet all other terms and conditions of the program.

Click here to enroll your patient in the Organon Co-pay Assistance Program.

Organon Patient Assistance Program

Representatives of The Organon Access Program can refer patients to the Organon Patient Assistance Program. This private and confidential program provides product free of charge to eligible patients who do not have insurance, or who cannot afford Ontruzant even with prescription drug coverage. Individuals who don’t meet the insurance criteria may still qualify for this program if they attest that they have special circumstances of financial and medical hardship, and their income meets the program criteria. A single application may provide for up to 1 year of product free of charge to eligible individuals and an individual may reapply as many times as needed. Your patients may be eligible for this program if they:

  • Are a US resident
  • Have a prescription for Ontruzant from a healthcare provider licensed in the United States
  • Do not have insurance or other coverage for a prescription medicine
  • Cannot afford to pay for their medicine
  • Meet certain financial requirements.

Click here for more information on the program. To request a referral to the Organon Patient Assistance Program, click here.

TABLE Organon Biosimilar Oncology Drug

Drug
Indications
Patient support programs

Drug
Ontruzant (trastuzumab-dttb) for injection
Indications
HER2-overexpressing breast cancer; HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma as determined by an FDA-approved companion diagnostic for a trastuzumab product
Patient support programs